ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹922 Cr | ₹819 Cr | ₹666 Cr | ₹560 Cr | ₹450 Cr |
What is the latest Revenue of ORCHID PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹922 Cr |
| Mar2024 | ₹819 Cr |
| Mar2023 | ₹666 Cr |
| Mar2022 | ₹560 Cr |
| Mar2021 | ₹450 Cr |
How is Revenue of ORCHID PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹922 Cr | 12.52 | |
| Mar2024 | ₹819 Cr | 23.05 | |
| Mar2023 | ₹666 Cr | 19.00 | |
| Mar2022 | ₹560 Cr | 24.33 | |
| Mar2021 | ₹450 Cr | - | |
Compare Revenue of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,015.8 Cr | 0.3% | 7.7% | 41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 0.3% |
7.7% |
41.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses